# Evaluation of Data Obtained From Three Common Imaging Techniques: Positron Emission Tomography (PET-CT), Breast Ultrasound, and Magnetic Resonance Imaging (MRI) After Neoadjuvant Chemotherapy in Patients With Breast Cancer

> **NCT07441330** · NA · TERMINATED · sponsor: **Ramsay Générale de Santé** · enrollment: 42 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Breast ultrasound
- **PROCEDURE:** MRI
- **PROCEDURE:** TEP-TDM

## Key facts

- **NCT ID:** NCT07441330
- **Lead sponsor:** Ramsay Générale de Santé
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-03-31
- **Primary completion:** 2025-03-31
- **Final completion:** 2025-03-31
- **Target enrollment:** 42 (ACTUAL)
- **Why stopped:** difficulty in including patients
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07441330

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07441330, "Evaluation of Data Obtained From Three Common Imaging Techniques: Positron Emission Tomography (PET-CT), Breast Ultrasound, and Magnetic Resonance Imaging (MRI) After Neoadjuvant Chemotherapy in Patients With Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07441330. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*